Apelacio, Alvie T.

HRN: 21-65-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/15/2022
08/22/2022
IV
600mg
Q6
Abscess Right Lower Lip
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: